A Study in Healthy Smokers to Investigate the Effect of Food on the Bioavailability of Cytisine in a New Formulation

Summary

This will be an open-label, randomised, 2-treatment period, single-dose crossover study to determine the comparative bioavailability and renal elimination following single-dose administration of 3.0 mg cytisine in healthy smokers under fed and fasted conditions.

Timeline

Start

2018-04-27

Primary completion

2018-06-10

Completion

2018-06-12

Drugs

Indications

No indication recorded.